Dyadic International (DYAI) Research & Development (2018 - 2026)
Dyadic International's Research & Development was $476,069 in Q1 2026, down 3.8% from $494,979 a year earlier but up 3.8% from the prior quarter.
Powered by 
Analysis
Dyadic International (DYAI) Research & Development (2018 - 2026) Analysis & Trends
On a trailing twelve-month basis, Dyadic International's Research & Development was $2.14 million through Mar 31, 2026, up 5.9% year-over-year; for FY2025, it came in at $2.15 million, up 5.4% from FY2024.
- Research & Development shows a five-year compound annual growth rate of -11.0% (FY2020 to FY2025).
- In earlier years, Research & Development was $2.04 million in FY2024 (-38.0%), $3.3 million in FY2023 (-26.7%), $4.5 million in FY2022 (-46.4%) and $8.39 million in FY2021 (+117.0%).
- Quarterly Research & Development has moved between $458,436 (Q4 2025) and $2.21 billion (Q2 2021) over five years.
- Compared with a year earlier, Research & Development was higher in two of the last eight quarters, with an average decline of 11.8%.
- The best year-over-year quarter for Research & Development over five years was Q4 2021 (growth of 144.8%); the worst was Q1 2022 (a decline of 99.9%).
- Per Business Quant data, DYAI's Research & Development in the three quarters before Q1 2026 was $458,436 (Q4 2025), $571,872 (Q3 2025) and $629,379 (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Dyadic International | 16.03 Mn | 9.43 Mn | - | 476,069.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 476,069.00 |
| Dec 31, 2025 | 458,436.00 |
| Sep 30, 2025 | 571,872.00 |
| Jun 30, 2025 | 629,379.00 |
| Mar 31, 2025 | 494,979.00 |
| Dec 31, 2024 | 545,660.00 |
| Sep 30, 2024 | 460,241.00 |
| Jun 30, 2024 | 515,629.00 |
| Mar 31, 2024 | 522,723.00 |
| Dec 31, 2023 | 852,797.00 |
| Sep 30, 2023 | 716,351.00 |
| Jun 30, 2023 | 917,552.00 |
| Mar 31, 2023 | 810,566.00 |
| Dec 31, 2022 | 584,120.00 |
| Sep 30, 2022 | 743,585.00 |
| Jun 30, 2022 | 1.83 Mn |
| Mar 31, 2022 | 1.34 Mn |
| Dec 31, 2021 | 2.47 Mn |
| Sep 30, 2021 | 1.90 Mn |
| Jun 30, 2021 | 2.21 Bn |
API Access
Dyadic International Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=DYAI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "DYAI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=DYAI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();